Clinical trial
Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.
NCT00214552
Study timeline
Study start (unknown)2002-09-01Date precision: month
Registry last updated2011-06-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Asthmaunresolved
Gastroesophageal Reflux Diseaseunresolved
Interventions
rabeprazoleDRUG · verified · RxNorm: rabeprazole
Sponsors & collaborators
Associated Scientists to Help Minimize Allergieslead sponsor
Janssen Pharmaceuticalscollaborator
Eisai Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00214552 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.